LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Simple Saliva Test May Help Diagnose Kidney Disease

By Michal Siman-Tov
Posted on 29 Nov 2016
Print article
A preliminary study suggests that a dipstick test for salivary urea nitrogen could be accurate for diagnosing kidney disease and may help predict patients' risk of early death. The test would be especially helpful in developing countries where simple and inexpensive tools for diagnosing kidney disease are most needed.

The study was highlighted at the American Society of Nephrology’s (Washington, DC, USA) Kidney Week 2016 (November 15-20, Chicago, IL, USA), and summarized in Abstract 5710 under the title "Saliva Urea Nitrogen Dipstick: a simple tool to detect and stratify risk of renal disease in low resource settings."

Viviane Calice-Silva, MD, PhD, of the Pro-Kidney Foundation in Brazil, and colleagues evaluated the diagnostic performance of a salivary urea nitrogen (SUN) dipstick in Malawi, Africa, a low-resource country. Among 742 adult individuals who were studied, investigators diagnosed 146 patients with kidney disease using standard tests. High SUN levels were associated not only with the standard diagnostic tests, but also with a higher risk of early death.

"Our data suggest that SUN can improve the detection of kidney disease, increasing the awareness to this devastating complication," said Dr. Calice-Silva, "Also, higher awareness and detection of kidney disease in low-resource settings may increase the number of patients who are diagnosed and referred, therefore providing appropriate treatment and improving outcomes."

Related Links:
American Society of Nephrology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more